BPC 157: Everything You Need to KnowBenefits, Risks, Dosing, & Delivery Methods YouTube The internet says BPC 157 is banned the FDA says something more nuanced. At Moonshot Medical in Park Ridge, IL, we provide honest, current guidance on peptide therapy through licensed compounding pharmacies. The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency Chemical Research in Toxicology BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat Cerovecki 2010 Journal of Orthopaedic Research Wiley Online Library